| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 05/02/2002 | EP1200398A1 3-arylsulfonyl-2-(substituted methyl)propanoic acid derivates as matrix metalloproteinase inhibitors |
| 05/02/2002 | EP1200133A1 Manipulation of tissue or organ type using the notch pathway |
| 05/02/2002 | EP1200130A2 Methods for treating therapy-resistant tumors |
| 05/02/2002 | EP1200125A1 Psca: prostate stem cell antigen and uses thereof |
| 05/02/2002 | EP1200124A1 Immunoglobulin fusion proteins |
| 05/02/2002 | EP1200123A1 Diagnosis and treatment of neuroectodermal tumors |
| 05/02/2002 | EP1200116A2 USE OF FVIIa OR A TISSUE FACTOR ANTAGONIST FOR REGULATING GENE EXPRESSION AND CELL MIGRATION OR CHEMOTAXIS |
| 05/02/2002 | EP1200114A2 Ppar delta inhibitors for the treatment of cardiovascular diseases |
| 05/02/2002 | EP1200108A1 Use of ginkgo extract |
| 05/02/2002 | EP1200101A1 Methods for transdifferentiation of body tissues |
| 05/02/2002 | EP1200099A1 Synergistic composition comprising daunorubicin derivatives and antimetabolite compounds |
| 05/02/2002 | EP1200098A2 Combined preparations comprising daunorubicin derivatives and anti her2 antibodies |
| 05/02/2002 | EP1200097A2 Method for controlling the fidelity and the execution of reverse transcriptase by incorporating and polymerising nucleotide analogues accepted as substrates of the reverse transcription response without blocking its elongation |
| 05/02/2002 | EP1200095A1 Medicament with a protective effect against oxidative-toxic substances, particularly against cardiotoxic substances |
| 05/02/2002 | EP1200086A2 Methods for treating or preventing pain and anxiety |
| 05/02/2002 | EP1200085A1 Pharmaceutical and nutritional compositions containing essential fatty acids and homocysteine-lowering agents |
| 05/02/2002 | EP1200074A2 Use of diphenyliodonium for the activation and protection of cytotoxic lymphocytes |
| 05/02/2002 | EP1200068A2 Liposomal prodrugs comprising derivatives of camptothecin and methods of treating cancer using these prodrugs |
| 05/02/2002 | EP1200067A1 Delivery system for biological material |
| 05/02/2002 | EP1199996A1 Real-time monitoring of photodynamic therapy over an extended time |
| 05/02/2002 | EP1173192A4 Methods and compositions for targeted drug delivery |
| 05/02/2002 | EP1146875A4 Myt1 kinase inhibitors |
| 05/02/2002 | EP1089726B1 Composition comprising ss-hydroxy-ss-methylbutyric acid and at least one amino acid |
| 05/02/2002 | EP0833628A4 Novel taxoids |
| 05/02/2002 | EP0814784B1 USE OF NSAIDs FOR TREATMENT OF SQUAMOUS CELL CARCINOMAS OF THE ORAL CAVITY OR OROPHARYNX |
| 05/02/2002 | EP0724884B1 Side effect inhibitor for cancer therapy |
| 05/02/2002 | EP0615448B1 Sex steroid activity inhibitors |
| 05/02/2002 | DE10053474A1 Schwefelhaltige Indirubinderivate, deren Herstellung und Verwendung Sulfur-containing indirubin derivatives, their preparation and use |
| 05/02/2002 | DE10052658A1 Neue Pyranosidderivate New Pyranosidderivate |
| 05/02/2002 | DE10052333A1 Neue Sulfooxybenzamide New Sulfooxybenzamide |
| 05/02/2002 | CA2678256A1 Methods of treating vascular diseases characterized by nitric oxide insufficiency |
| 05/02/2002 | CA2464228A1 Vaccine immunotherapy for immune suppressed patients |
| 05/02/2002 | CA2427085A1 Transmembrane proteins |
| 05/02/2002 | CA2427070A1 Preferred segments of neural thread protein and methods of using the same |
| 05/02/2002 | CA2427068A1 Method for introducing antisense oligonucleotides into eucaryotic cells |
| 05/02/2002 | CA2427024A1 Methods for screening compounds that modulate lipid metabolism |
| 05/02/2002 | CA2427005A1 Multi-component antioxidant compounds, pharmaceutical compositions containing same and their use for reducing or preventing oxidative stress |
| 05/02/2002 | CA2426898A1 A combination comprising camptothecin and a stilbene derivative for the treatment of cancer |
| 05/02/2002 | CA2426896A1 Compositions and methods for the discovery and selection of biological information |
| 05/02/2002 | CA2426741A1 Aliphatic amino-substituted demethoxylated hypocrellins and their synthesis |
| 05/02/2002 | CA2426736A1 Vegf peptides and their use for inhibiting angiogenesis |
| 05/02/2002 | CA2426602A1 Polymer based radionuclide containing particulate material |
| 05/02/2002 | CA2426564A1 Pyranoside derivatives |
| 05/02/2002 | CA2426360A1 Enhancers for microbiological disinfection and targeted apoptosis |
| 05/02/2002 | CA2426244A1 Lipid formulations for target delivery |
| 05/02/2002 | CA2426203A1 Anticancer agents based on regulation of protein prenylation |
| 05/02/2002 | CA2426007A1 A novel crystalline form of 6-hydroxy-3-(4-[2-(piperidin-1-yl)ethoxy]phenoxy)-2-(4-methoxyphenyl)benzo[b]thiophene hydrochloride |
| 05/02/2002 | CA2425770A1 Using heat shock proteins to increase immune response |
| 05/02/2002 | CA2425288A1 Pyrrolidine modulators of ccr5 chemokine receptor activity |
| 05/02/2002 | CA2425283A1 Spiro-pyrimidine-2,4,6-trione metalloproteinase inhibitors |
| 05/02/2002 | CA2425280A1 Pyrimidine-2,4,6-trione metalloproteinase inhibitors |
| 05/02/2002 | CA2421885A1 Methods of treating vascular diseases characterized by nitric oxide insufficiency |
| 05/02/2002 | CA2420164A1 Acylsemicarbazides and their use as cyclin dependent kinase (cdk) inhibitors |
| 05/02/2002 | CA2326004A1 Methods for treating cellular proliferative disorders |
| 05/01/2002 | CN1347418A Novel nucleosides and oligonucleotide analogues |
| 05/01/2002 | CN1347416A Substd. 3-cyano-[1.7], [1.5], and [1.8]-naphthyridine inhibitors of tyrosine kinases |
| 05/01/2002 | CN1347411A Sulfonamide derivs. having oxadiazole rings |
| 05/01/2002 | CN1347327A Methods for glucagon suppression |
| 05/01/2002 | CN1347326A BAFF, inhibitors thereof and their use in modulation of B-cell response |
| 05/01/2002 | CN1347325A Novel amide derivs. as growth hormone secretagogues |
| 05/01/2002 | CN1347323A Chemical compounds |
| 05/01/2002 | CN1347322A Chemical compounds |
| 05/01/2002 | CN1347318A Inhibitors of IMPDH enzyme |
| 05/01/2002 | CN1347317A Remedies |
| 05/01/2002 | CN1346679A Immobilized isomerous tumor vaccine and its preparing process |
| 05/01/2002 | CN1346677A Medicine for preventing cancer and its application method |
| 05/01/2002 | CN1346669A Medicine for preventing and treating cancer and its preparing process |
| 05/01/2002 | CN1346659A Anticancer health-care Chinese yew composition |
| 05/01/2002 | CN1346654A Natural medicine material for interiorly eliminating cancer and its preparation |
| 05/01/2002 | CN1346641A Freezed dried centipede |
| 05/01/2002 | CN1083830C Substd. benzamidines, their production and their use as medicaments |
| 05/01/2002 | CN1083725C Cordyceps medicine composition and its preparing method |
| 05/01/2002 | CN1083714C Microcapsule contg. chemotherapeutic medicine and capsule-forming method |
| 04/30/2002 | US6380408 Non-calcemic, antiproliferative, transcriptionally active sulfur-containing analogs of 1α, 25-dihydroxy vitamin D3 |
| 04/30/2002 | US6380405 Taxane prodrugs |
| 04/30/2002 | US6380403 Illudin analogs useful as antitumor agents |
| 04/30/2002 | US6380395 Anticancer agents |
| 04/30/2002 | US6380394 Anticancer agents |
| 04/30/2002 | US6380360 Polycystic kidney disease 1 gene and uses thereof |
| 04/30/2002 | US6380258 Sulfonyl divalent aryl or heteroaryl hydroxamic acid compounds |
| 04/30/2002 | US6380251 Therapy of ocular hypertension which comprises administering cyclopentane heptan(ene)oic acid or its 2-thiocarbamoyloxy and 2-carbamoyloxy derivatives |
| 04/30/2002 | US6380250 Therapy of ocular hypertension which comprises administering cyclopentane heptan(ene)oic acid or its 2-thiocarbamoyloxy and 2-carbamoyloxy derivatives |
| 04/30/2002 | US6380239 For therapy of arthritis, rheumatoid arthritis, osteoarthritis, reperfusion injury, inflammatory bowel disease, crohn's disease, ulcerative colitis, systemic lupus erythrematosis, scleroderma, aphthous ulcers, asthma |
| 04/30/2002 | US6380235 Useful as progesterone receptor agonists and antagonists, used for contraception, in therapy of fibroids, endometriosis, breast, uterine, ovarian and prostate cancer, and post menopausal hormone replacement therapy |
| 04/30/2002 | US6380227 Fermentative preparation process for and crystal forms of cytostatics |
| 04/30/2002 | US6380220 Therapy of neurodegenerative diseases and neuronal injuries which are casued by ischemia, trauma or massive hemorrhages |
| 04/30/2002 | US6380219 For therapy of arthritis, cancer, tissue ulceration, restenosis, peridontal disease, epidermolysis bullosa, scleritis and other diseases characterized by matrix metalloproteinase activity, sepsis, septic shock |
| 04/30/2002 | US6380214 Thiophene-3-carboxylic acid amide derivatives |
| 04/30/2002 | US6380211 For treating diabetes |
| 04/30/2002 | US6380191 Arylthiazolidinedione and aryloxazolidinedione derivatives |
| 04/30/2002 | US6380170 Nucleic acid construct for the cell cycle regulated expression of structural genes |
| 04/30/2002 | US6380167 Methods for anti-tumor therapy |
| 04/30/2002 | US6380162 Ice inhibiting peptides |
| 04/30/2002 | US6380157 Administering medicament comprising papillomavirus l2 protein, or a therapeutically effective fragment thereof for therapy of papillomavirus infection |
| 04/30/2002 | US6380156 Having antiviral, antitumor, and immunosuppressive activities |
| 04/30/2002 | US6379950 Recombinant, active caspases and uses thereof |
| 04/30/2002 | US6379945 Gene switch |
| 04/30/2002 | US6379927 Retinoblastoma fusion proteins |
| 04/30/2002 | US6379923 ELL2, a new member of an ELL family of RNA polymerase II elongation factors |
| 04/30/2002 | US6379674 Use of herpes vectors for tumor therapy |